Clinical Study of a 3D Shaded Zirconia for Chairside CAD/CAM Restorations

NCT06713577 | Active Not Recruiting FDA Device

• 2 other identifiers: C-RE-24-018HUM00263115
• Study Type: observational
• Target: 82
• Locations: 1 country
• Sites: 1

Brief Summary

This investigation will be a prospective, longitudinal clinical trial to study the clinical performance of a new monolithic, 3D shaded zirconia material for computer assisted design and computer assisted machining for chairside restorations. The restorations will be evaluated for a period of up to five years. The study is called Clinical Study of a 3D Shaded Zirconia for chairside computer assisted design and computer assisted machining (CAD/CAM) chairside restorations intended to be part of the validation plan and post market follow-up of the following products: CEREC Cercon 4D, Calibra Universal +, and Prime and Bond Active.

Conditions

Dental Prosthesis Failure; Dental Prosthesis Complication

Outcome Measures

Primary Outcomes (1)

• Evaluation of the longitudinal clinical performance of 3D shaded zirconia onlays, crowns and FPDs.

  The restorations will be evaluated according to the modified World Dental Federation notation (FDI) criteria for maintaining their esthetic functional and biological properties.

  At the five year follow up

Secondary Outcomes (3)

• Evaluation of the longitudinal clinical performance of 3D shaded zirconia onlays, crowns and FPDs.

  At the 6 month, 1 year, 2 year, 3 year and 4 year follow up

• Evaluation of the resistance of the material chipping and fracture of the reduce thickness zirconia CAD/CAM onlays, crowns and FPDs.

  At the 6 month, 1 year, 2 year, 3 year and 4 year and 5 year follow up.

• Evaluation of the short-term post operative sensitivity associated with cementation techniques using a self-adhesive, universal resin cement and a selective etch/universal bonding agent with a universal resin cement.

  Once a week after base line up to four weeks or until patient is asymptomatic.

Study Arms (3)

Group 1 Crowns

35 crowns delivered with a universal resin cement (Calibra Universal + by Dentsply Sirona).

Device: CEREC Cercon 4D

Group 2 Onlays

35 onlays delivered with selective enamel etch, bonding agent, and universal resin cement (Prime \& Bond Active with Calibra Universal + by Dentsply Sirona).

Device: CEREC Cercon 4D

Group 3 Fixed Partial Dentures (FPD)

12 Fixed Partial Dentures (FPD) delivered with a universal resin cement (Calibra Universal + by Dentsply Sirona).

Interventions

CEREC Cercon 4D DEVICE

One investigational medical device is a new generation of a full contour zirconia restorative material (CEREC Cercon 4D/Dentsply Sirona) for chairside computer assisted design/computer assisted machines (CAD/CAM) restorations. It has an internal core of 4 mol% (4Y) zirconia transitioning to an external layer of 4/5 mol% (4/5 Y) zirconia with a three-dimensional gradient of shade from an inner chromatic layer to an external translucent layer that replicates the natural structure and appearance of a tooth. It is indicated for crowns, bridges, veneers, inlays and onlays and implant crowns Clinical Study of a 3D Shaded Zirconia for Chairside CAD/CAM Restorations The other investigational medical devices are a universal bonding agent (Prime and Bond Active/Dentsply Sirona) and dual-cure, self-adhesive resin cement (Calibra Universal +/Dentsply Sirona). They are used in combination to deliver ceramic and zirconia restorations.

Group 1 Crowns; Group 2 Onlays

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The patient population will be selected from current patients of either gender and any ethnic background, under clinical treatment at the University of Michigan Dental Clinics.

You may qualify if:

• Adult aged 18-75 years.
• Willing and able to sign and date the informed consent form and the HIPAA form.
• Onlays and Crowns: Each patient should have at least one carious lesion, defective restoration, or fractured portion of the tooth to be restored on a maxillary or mandibular premolar or molar tooth. Each lesion, fracture, or defective restoration should exhibit sufficient size or loss of tooth structure requiring an onlay or crown restoration. The tooth should have at least one opposing tooth in occlusion and one adjacent tooth with an intact proximal contact. No more than eight teeth that are endodontically treated and restorable with an onlay or crown may be included in the study. All remaining teeth in the study will test vital and be asymptomatic at the beginning of treatment. No more than two restorations will be placed per patient. If a patient presents with more than two acceptable teeth for the study, molar teeth will be included prior to premolar teeth.
• Fixed Partial Dentures (FPDs): Each patient should have at least one missing tooth, either anterior or posterior, that is appropriate for replacement with a fixed partial denture. Abutment teeth will have healthy periodontal status with at least a 1:1 crown:root ratio. The FPD should have at least two opposing teeth in occlusion and one adjacent tooth with an intact proximal contact. Both abutment teeth must be asymptomatic prior to treatment. Endodontically treated teeth will be acceptable for abutments if nonmetallic cores can be placed to retain the FPD. FPDs may include 3 or 4 teeth as indicated by the clinical situation but must be within the 43 mm span of the mill block to manufacture it as described later. The patient cohort should include a mix of non-endodontically as well as endodontically treated teeth.

You may not qualify if:

• Unlikely to be able to comply with clinical study procedures, according to Principal Investigator's (PIs) judgment.
• Subject is not willing to participate in the clinical study.
• Patients unable to return for the recall appointments for a period of 5 years.
• Severe non-compliance to the clinical study plan as judged by the PI and/or Dentsply Sirona.
• Involvement in the planning and conduct of the clinical study. Applies to both Dentsply Sirona personnel and personnel from the clinical study site.
• Sensitive teeth.
• Teeth diagnosed with symptoms of incomplete tooth fracture.
• Teeth with a history of direct or indirect pulp capping procedures.
• Patients with significant untreated dental disease to include periodontitis and/or rampant caries.
• Women who self-report that they are possibly pregnant, pregnant, or lactating, as elective dental treatment is not indicated at these times.
• Patients with a self-reported history of allergies to the materials to be used in the study including composite resin cements, provisional acrylics, or zirconia restorative materials.

Sponsors & Collaborators

• Dentsply Sirona Implants and Consumables: lead

Study Sites (1)

Department of Cariology, Restorative Sciences, and Endodontics at School of Dentistry

Ann Arbor, Michigan, 48109-1078, United States

Location

Study Officials

• Dennis J Fasbinder

  Clinical Professor of Dentistry, Department of Cardiology, Restorative Sciences, and Endodontics

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 27, 2024
• First Posted: December 3, 2024
• Study Start: December 3, 2024
• Primary Completion (Estimated): January 22, 2031
• Study Completion (Estimated): November 22, 2031
• Last Updated: March 9, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)